Related Experiment Video

Updated: Aug 14, 2026

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

Instant dissolution of intracoronary thrombus by abciximab

Chi Hang Lee, Kheng Thye Ho, Huay Cheem Tan

    International Journal of Cardiology
    |September 3, 2005
    PubMed

    Insights

    Sudden intracoronary thrombus formation during percutaneous coronary intervention can cause myocardial infarction. Prompt intracoronary abciximab effectively dissolved the thrombus, preventing myocardial damage and allowing the procedure to proceed.

    Area of Science:

    • Cardiology
    • Interventional Cardiology
    • Thrombosis Management

    Background:

    • Intracoronary thrombus formation during percutaneous coronary intervention (PCI) poses a risk of acute vessel closure and myocardial infarction.
    • Mechanical thrombectomy is a standard treatment for thrombus removal.
    • Prompt intervention is crucial to prevent adverse cardiac events.

    Observation:

    • A rare case of immediate thrombus formation post-guidewire advancement during PCI is presented.
    • This thrombus caused acute myocardial ischemia.
    • Intracoronary administration of abciximab was employed as an intervention.

    Findings:

    • Intracoronary abciximab resulted in prompt and complete dissolution of the intracoronary thrombus.
    • The PCI procedure was completed without complications.
    • No myocardial damage was observed post-intervention.

    Implications:

    • Intracoronary abciximab may offer a more effective alternative to intravenous administration for managing acute coronary syndromes during PCI.
    • This approach could improve outcomes and reduce myocardial damage in emergent coronary interventions.
    • Further research into intracoronary abciximab administration in PCI is warranted.

    More Related Videos

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

    Published on: May 28, 2019

    Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model05:52

    Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

    Published on: November 4, 2021

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...